Vaccine hesitancy, state bias, and Covid-19: Evidence from a survey experiment using Phase-3 results announcement by BioNTech and Pfizer.

ABSTRACT:

Background

Past survey studies document that people strongly prefer Covid-19 vaccines developed domestically over those developed abroad. Available evidence suggests that this preference for domestic vaccines over foreign ones may stem from prejudice against foreign countries, but identifying prejudice-based vaccine preferences is difficult because people also draw inferences about the quality of vaccines based on country of origin. We exploit a unique opportunity provided by the announcement of a viable vaccine by a bi-national venture, BioNTech and Pfizer, to examine the effect of such prejudice on vaccination intentions while controlling for beliefs about the vaccine quality.

Methods

We implemented a survey experiment in Germany and the United States (n = 582, 661 respect

SUBMITTER: Kobayashi Y 

PROVIDER: S-EPMC8205290 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature